🇺🇸 FDA
Patent

US 7101852

Composition and method for treatment and prevention of restenosis

granted A61KA61K38/00A61P

Quick answer

US patent 7101852 (Composition and method for treatment and prevention of restenosis) held by The Board of Regents of the University of Texas System expires Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 05 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 31 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/00, A61P, A61P35/04